Pennington, NJ, United States of America

John H Lawrence

This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John H Lawrence. Retrieved from https://idiyas.com/inventor/john-h-lawrence-63yluvee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Gene Delivery: The Contributions of John H. Lawrence

Introduction

John H. Lawrence is an accomplished inventor based in Pennington, NJ, renowned for his pioneering work in the field of nucleic acid delivery. His contributions are critical for advancing gene therapy and enhancing the effectiveness of medical treatments involving genetic material transfer.

Latest Patents

Lawrence holds a significant patent titled "Methods and Compositions for Nucleic Acid Delivery." This innovative patent outlines methods and compositions that enable the efficient delivery of nucleic acids to specific cells, particularly within solid organs, such as the mammalian heart. The invention enhances gene transfer and subsequent expression within the majority of cells throughout the targeted organ. Notably, these methods improve vascular permeability, facilitating increased gene transfer to the chosen cells while minimizing degradation or injury to endothelial cell layers.

Career Highlights

Currently, John H. Lawrence is associated with The Johns Hopkins University, where he continues to contribute to groundbreaking research and technological advancements. His expertise and inventions play a vital role in the ongoing pursuit of effective gene therapies that could revolutionize treatments for various diseases.

Collaborations

Throughout his career, Lawrence has collaborated with distinguished colleagues such as J. Kevin Donahue and Eduardo Marban. These partnerships exemplify the combined efforts that drive innovations in medical research and technology, showcasing the importance of teamwork in achieving successful outcomes.

Conclusion

John H. Lawrence's contributions to the field of nucleic acid delivery represent a significant advancement in the realm of gene therapy. His endeavors not only enhance our understanding of gene transfer mechanisms but also pave the way for future innovations that can transform medical treatments and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…